548 related articles for article (PubMed ID: 7956212)
21. Enlarged follicles in women using oral contraceptives.
Broome M; Clayton J; Fotherby K
Contraception; 1995 Jul; 52(1):13-6. PubMed ID: 8521709
[TBL] [Abstract][Full Text] [Related]
22. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
Straznicky NE; Barrington VE; Branley P; Louis WJ
J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
[TBL] [Abstract][Full Text] [Related]
23. Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
Weir RJ
Scott Med J; 1982 Jul; 27(3):212-5. PubMed ID: 6810459
[TBL] [Abstract][Full Text] [Related]
24. Effect of desogestrel-containing oral contraceptives on vascular reactivity and catecholamine levels.
Arangino S; Cagnacci A; Angiolucci M; Longu G; Melis GB; Volpe A
Contraception; 1998 Nov; 58(5):289-93. PubMed ID: 9883384
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
Moore LL; Valuck R; McDougall C; Fink W
Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
[TBL] [Abstract][Full Text] [Related]
26. Hormonal contraception and lactation.
Kelsey JJ
J Hum Lact; 1996 Dec; 12(4):315-8. PubMed ID: 9025449
[TBL] [Abstract][Full Text] [Related]
27. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Akerlund M; Røde A; Westergaard J
Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
[TBL] [Abstract][Full Text] [Related]
28. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
29. Concentration of fat, protein, lactose and energy in milk of mothers using hormonal contraceptives.
Costa TH; Dorea JG
Ann Trop Paediatr; 1992; 12(2):203-9. PubMed ID: 1381897
[TBL] [Abstract][Full Text] [Related]
30. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
31. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
32. Effects of contraceptives on hemoglobin and ferritin. Task Force for Epidemiological Research on Reproductive Health, United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.
Contraception; 1998 Nov; 58(5):262-73. PubMed ID: 9883381
[TBL] [Abstract][Full Text] [Related]
33. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
[TBL] [Abstract][Full Text] [Related]
34. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Berenson AB; Wiemann CM
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptive use and blood pressure in a German metropolitan population.
Cairns V; Keil U; Doering A; Koenig W; Stieber J; Kleinbaum DG
Int J Epidemiol; 1985 Sep; 14(3):389-95. PubMed ID: 3877006
[TBL] [Abstract][Full Text] [Related]
36. Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.
Brill K; Norpoth T; Schnitker J; Albring M
Contraception; 1991 Feb; 43(2):101-10. PubMed ID: 2040166
[TBL] [Abstract][Full Text] [Related]
37. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Prasad RN; Liew D; Ratnam SS
Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
[TBL] [Abstract][Full Text] [Related]
38. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
39. The effects of Implanon on lipid metabolism in comparison with Norplant.
Suherman SK; Affandi B; Korver T
Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
[TBL] [Abstract][Full Text] [Related]
40. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
